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Coxiella burnetii replicates as distinct morphological forms, which may allow potential life cycle variants to
survive the harsh environment of the phagolysosome. Monoclonal antibodies (MAbs) were compared by
Western blotting for reactivity with large cell variant (LCV) and small cell variant (SCV) antigens to char-
acterize proteins differentially expressed by C. burnetii. MAb NM7.3 reacted with a ;32-kDa LCV-upregulated
antigen, and MAb NM183 reacted with a ;45-kDa LCV-specific antigen. MAb NM7.3 was used to screen a
lZapII C. burnetii DNA expression library, and an immunoreactive clone was identified with sequence simi-
larity to the Escherichia coli tsf gene, which encodes elongation factor Ts (EF-Ts). Since a similar screen with
MAb NM183 did not identify immunoreactive clones, an alternate strategy was devised to clone the reactive
antigen based on observations of cross-reactivity with the 45-kDa elongation factor Tu (EF-Tu) protein from
Chlamydia trachomatis. The highly conserved nature of EF-Tu among eubacteria allowed PCR amplification of
a tuf gene fragment (encoding ;95% of the predicted EF-Tu open reading frame) from C. burnetii using
degenerate primers. The product of the cloned tuf gene fragment reacted with MAb NM183 in Western blot
analysis, confirming the identity of the 45-kDa LCV-specific antigen. Identification of two proteins differentially
expressed by C. burnetii, EF-Tu and EF-Ts, both essential components of the translational machinery of the
cell, supports the hypothesis that LCVs are metabolically more active than SCVs.
Coxiella burnetii, the etiological agent of Q fever, is an ob-
ligate intracellular rickettsial pathogen with worldwide distri-
bution and a broad host range that includes livestock and
humans (3). Human disease is contracted mainly by inhaling
aerosolized bacteria and is associated with domestic animal
operations, putting workers at increased risk of infection (2).
An acute Q fever typically presents as a flu-like illness, but
occasional chronic infections occur which may manifest as en-
docarditis or hepatitis, resulting in significant mortality (4).
An extraordinary ability to persist in the environment is a
hallmark of C. burnetii, and the basis for this stability may be
the expression of resistant cell forms. C. burnetii appears to
undergo an incompletely characterized life cycle within the
phagolysosome of the eukaryotic host cell with at least two
distinct morphological forms, designated large cell variant
(LCV) and small cell variant (SCV) (7, 11, 17, 19, 21). These
two forms have been characterized primarily by ultrastructural
differences (17, 19): LCVs appear similar to typical gram-
negative bacteria during exponential-phase growth with a
clearly distinguishable outer membrane, periplasmic space, cy-
toplasmic membrane, and diffuse nucleoid, attaining lengths
exceeding 1 mm. SCVs are 0.2 to 0.5 mm in diameter with
electron-dense, condensed chromatin and condensed cyto-
plasm. SCVs are resistant to osmotic shock, oxidative stress,
heat shock, sonication, and pressure, unlike the more fragile
LCVs (1, 9, 18). Differences in resistance to breakage by os-
motic and pressure stresses were employed to determine that
LCVs may have greater metabolic activity than SCVs based on
their ability to metabolize [14C]glucose and [14C]glutamate in
axenic media (18). Limitations of this study included the facts
that reduced activity may have been the consequence of the
extreme osmotic shock conditions to which the cells were sub-
jected and that the activity evaluated in axenic medium may
not accurately reflect events in the intraphagolysosomal com-
partment. Therefore, these data did not conclusively establish
a metabolic activity difference between SCVs and LCVs.
SCVs and LCVs can be separated to near homogeneity by
gradient density centrifugation in 32% cesium chloride (10, 12,
25). Heinzen and coworkers demonstrated the abundance of a
specific histone-like DNA binding protein (Hq-1) in SCV
which may function in regulating gene expression by inducing
topological changes in DNA (10, 14). This group also de-
scribed a small, basic peptide (ScvA) only expressed by SCV,
which might function in DNA binding or nutrient storage dur-
ing extended periods of metabolic inactivity (12).
We speculated that characterizing additional differentially
expressed proteins would provide insight into the function of
the life cycle variants. A panel of monoclonal antibodies raised
against formalin-killed C. burnetii was screened to identify pro-
teins differentially expressed by LCV and SCV. This study
presents the cloning and sequence analysis of two genes, des-
ignated tsf and tufB, encoding two immunoreactive antigens:
elongation factor Ts (EF-Ts), that shows LCV-upregulated
expression, and elongation factor Tu (EF-Tu), which appears
to be LCV-specific and is not present at a detectable level in
the SCV. These proteins are key components of the transla-
tional machinery of bacteria. Our findings, coupled with the
SCV-specific expression of DNA-binding proteins, support the
early observations regarding differences in the metabolic activ-
ities of LCV and SCV.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and growth conditions. Bacterial isolates
(C. burnetii, Escherichia coli, and Chlamydia trachomatis) and plasmids used in
this study are listed in Table 1. E. coli DH5a cultures were grown in Luria-
Bertani medium at 37°C in a shaking water bath; E. coli MRF cells were infected
with bacteriophage lZapII cloning vector (Stratagene, La Jolla, Calif.) and
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grown in top agar on NZY agar plates. Bacteriophage plaques were removed
with sterile Pasteur pipettes and were transferred to phage dilution SM buffer,
and plasmids were excised as described in the Stratagene lZapII-EcoRI-CIAP
cloning kit instruction manual. In order to maintain plasmids in E. coli, antibi-
otics were incorporated into the media (100-mg of ampicillin ml21 and 50-mg of
kanamycin ml21). C. burnetii was grown in embryonated yolk sacs and was
purified as previously described (23).
Preparation of MAb. Monoclonal antibodies (MAbs) were generated against
formalin-inactivated C. burnetii. Hybridoma cell lines were created by using a
standard mouse hybridoma fusion protocol (8). Briefly, three mice were immu-
nized with 50 mg of inactivated bacteria four times at 14-day intervals. Two
mouse spleens were used to isolate splenocytes which were then fused with
Sp2/O-Ag-14 myelomas (American Type Culture Collection, Rockville, Md.),
and hybridoma cultures which produced C. burnetii-reactive antibodies were
detected with an enzyme-linked immunosorbent assay against whole organisms.
Reactive clones were subcloned by limiting dilution, were tested for reactivity by
Western blotting and by immunofluorescence assay using infected L929 cells,
and were used to prepare ascitis fluid (8). Only MAbs which did not react with
E. coli proteins were maintained.
Isolation of chromosomal and plasmid DNAs. C. burnetii Nine Mile phase I
chromosomal DNA was extracted by a thermolysin-sodium dodecyl sulfate
(SDS) procedure (22). Plasmid minipreps were prepared by an alkaline lysis
procedure (Qiagen, Valencia, Calif.).
Screening of a C. burnetii genomic library. The MAbs designated NM7.3 and
NM183 were used to screen a bacteriophage lZapII genomic DNA library of the
C. burnetii Nine Mile isolate for clones expressing the immunoreactive antigen.
The C. burnetii genomic DNA library was constructed with EcoRI partially
digested chromosomal DNA fragments ligated with EcoRI-digested lZapII arms
as described in the Stratagene lZapII cloning kit manual. Bacteriophage lZapII
was mixed with E. coli MRF and was incubated on NZY agar plates to yield
approximately 500 plaques per plate. Plates were incubated overnight at 37°C to
obtain visible plaques. Isopropyl-b-D-thiogalactopyranoside (IPTG) induction
was conducted by overlaying plates with nitrocellulose membranes soaked in 10
mM IPTG and incubating for 10 h at 37°C. The membranes were screened by
Western blotting using either MAb NM7.3 or NM183. Once putative positive
clones were identified, secondary retesting was conducted to confirm positive
clones. These were subjected to in vivo excision to excise the pBluescript SK(2)
phagemid containing the cloned insert from the lZapII vector. These clones
were further characterized for production of the immunoreactive product by
incubating E. coli harboring the plasmid in Luria-Bertani broth supplemented
with 5 mM IPTG at 37°C overnight and then analyzing cell lysates by Western
blotting.
Separation of LCV and SCV. LCV and SCV were separated essentially as
described previously (10, 25). Nine Mile phase I bacteria were purified from
infected yolk sacs and then resuspended in 32% cesium chloride. This was
centrifuged at 27,000 rpm overnight and the resulting upper (SCV) and lower
bands (LCV) were separated and pelleted by centrifugation. Both forms were
resuspended in sucrose phosphate and were stored at 280°C until use.
Western blotting. C. burnetii or E. coli expressing cloned C. burnetii proteins
was resuspended in sample buffer (4% SDS, 10% b-mercaptoethanol, 20%
glycerol, and 0.25 M Tris, pH 8.0) and was boiled for 10 min, and solubilized
protein was separated by SDS-polyacrylamide gel electrophoresis (PAGE). Pro-
teins were transferred to nitrocellulose membranes and were reacted with anti-
bodies as previously described (13). MAbs against C. burnetii were prepared as
ascites and used at a 1:250 dilution. A horseradish-peroxidase-conjugated sec-
ondary antibody was used at a 1:1,000 dilution (Bio-Rad, Hercules, Calif.).
Anti-glutathione S-transferase (GST) antibody (Sigma, St. Louis, Mo.) was used
at a 1:1,000 dilution, and secondary anti-goat antibody (Sigma) was used at a
1:5,000 dilution. An estimation of the relative levels of EF-Ts expression by C.
burnetii LCV and SCV was determined by separating equal amounts of organ-
isms (as measured by optical density at 600 nm) and quantitating their Western
blot reactivities by using densitometric analysis (AlphaEase 3.22, Alpha Innotech
Corp., San Leandro, Calif.).
PCR amplification. All PCRs were carried out in a DNA thermo-cycler (Bi-
ometra, Tampa, Fla.) using a GenAmp kit (Perkin-Elmer, Branchburg, N.J.).
One-hundred-microliter reactions were carried out with Taq DNA polymerase
(Perkin-Elmer). Degenerate primers were ordered from Genosys Biotechnolo-
gies Inc., The Woodlands, Tex. Primers were designated P1 (59GAYTAYGTNA
ARAAYATG39), P2 (59RTCNCCNGGCATNACCAT39), and P3 (59TGGTAG
AGCRCWYSCWTGGTAAG39) and were used at final concentrations of 0.5
mmol per 100-ml reaction volume. The amplification procedure consisted of 30
cycles of 1 min at 95°C, 1 min at 45°C, and 1 min at 72°C. PCR products were
separated in a 1% agarose gel and were purified using a Geneclean kit (Bio 101,
Vista, Calif.). Desired PCR products were subsequently cloned into PCR cloning
vectors pCR2.1 TOPO-TA (Invitrogen, Carlsbad, Calif.) or pGEM-T (Promega,
Madison, Wis.).
Southern blotting. Genomic DNA from C. burnetii was digested with restric-
tion enzyme according to the manufacturer’s protocol (Boehringer Manheim,
Indianapolis, Ind.). DNAs were then electrophoresed through 0.8% agarose gels
and transferred to a nitrocellulose membrane (16a). Labeling of a DNA probe
with [a-P32]dCTP was carried out using a random DNA labeling Decaprime II
kit (Ambion, Austin, Tex.). Blots were incubated with probe overnight at 65°C
and then washed four times at high stringency for 30 min each at 65°C with 0.13
SSC (13 SSC is 0.15 M NaCl plus 0.015 M sodium citrate) containing 0.1% SDS.
Blots were analyzed for hybridization patterns on a phosphorimager image
reproduction (Model SF, Molecular Dynamics, Sunnyvale, Calif.).
DNA sequence analysis. All DNAs were sequenced at Gene Technology Lab-
oratories at Texas A & M University. Sequence homologies were compared using
MacVector and BLAST programs.
TABLE 1.
Strain or plasmid Relevent characteristics Source or reference
Strains
C. burnetii Nine Mile, phase I, RSA 493 23
C. trachomatis Biotype E American Type Culture Collection
E. coli DH5a F2 f80d lacZDM15D(lacZYA-argF)U169 deoR recA endA1 phoA supE44
l2thi-1 gyrA96 relA1
GIBCO/BRL
E. coli JM109 F9 traD 36 proAB lacIqZ D M15 recA1 endA1 gyrA96 thi-1 relA1 supE44
D(lac-proAB)
Promega
E. coli XL1-
MRF9
lac (F9 proAB lacIqZDM15 Tn10) (Tetr DmcrA) 183D(mcrCB-hsdSMR-mrr)
173 endA1 supE44 thi-1 recA1 gyrA96 relA1
Stratagene
E. coli SOLR F9 proAB lacIqZDM15 Su2(nonsupressing)lac gyrA96 relA1 thi-1 endA1 lR
sbcC recB recJ umuC::Tn5(Kanr) uvrC D(mcrCB-hsdSMR-mmr)171
Stratagene
E. coli
TOP10F9
F9[lacIq Tn10 (Tetr)] lacZDM15 DdeoR recA1 araD 139 D(ara-leu)7679
galU galK rpsL endA1 nupG mcrA D(mrr-hsdRMS-mcrBC)f80
Stratagene
Plasmids
pSKII(2) Cloning vector Apr Stratagene
pB1-7 pSKII(2) with 9-kb rpsB-tsf insert This work
pB1-7-L pSKII(2) with 4-kb EcoRI insert from pB1-7 This work
pB1-7-B pSKII(2) with 5-kb EcoRI insert from pB1-7 This work
pGEM-T PCR cloning vector Apr Promega
pROS100 pGEM-T with 900-bp tuf insert This work
pGEX-4T-1 GST gene fusion vector Apr Pharmacia
pROS101 pGEX4T-1 with 900-bp tuf insert This work
pROS102 pGEX4t-1 with 900-bp tuf insert (opposite orientation) This work
pCR2.1 TA cloning vector Apr Invitrogen
pROS103 pCR2.1 with 1,100-bp tuf insert This work
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Nucleotide sequence accession numbers. The sequences of rpsB-fts and tufB
have been deposited in GenBank under accession no. AF127534 and AF136604,
respectively.
RESULTS
Screening of MAb. MAbs were generated against C. burnetii
by immunizing mice with purified, formalin-killed organisms.
The immunoreactivities of antibodies produced by hybridoma
cell lines against C. burnetii proteins and absence of cross-
reactivity with E. coli antigens on enzyme-linked immunosor-
bent assay was determined, and C. burnetii-specific hybridomas
were cloned by limiting dilution. The antigen specificity of each
MAb was determined by Western blotting using purified C.
burnetii, and 10 MAbs were used in the survey to detect life
cycle-specific antigens. To detect differentially expressed anti-
gens, SCV and LCV were first separated by 32% cesium chlo-
ride isopycnic gradient centrifugation of purified organisms.
Whole-cell lysates of each form were then separated by SDS-
PAGE and were subsequently analyzed by immunoblotting
with different MAbs. MAb NM7.3 detected a 32-kDa antigen
that appeared to be produced by LCV at a level greater than
fourfold higher than in SCV (Fig. 1B) when compared by
scanning densitometry. MAb NM183 detected a 45-kDa anti-
gen in LCV but not in SCV (Fig. 1C). The total protein applied
to each lane of LCV and SCV was comparable, and several
proteins were used as controls, including ScvA (SCV specific)
(data not shown), Com-1 (not differentially expressed) (data
not shown), and C. burnetii macrophage infectivity potentiator-
like protein (Cb. Mip) (20) (Fig. 1A), which was expressed at
comparable levels by LCV and SCV.
Cloning of the gene encoding the 35-kDa antigen. Since
neither MAb cross-reacted with E. coli proteins, direct cloning
of the gene encoding this antigen was performed using a C.
burnetii gene bank expressed in E. coli. EcoRI-digested C.
burnetii Nine Mile DNA was ligated into lZapII and then
transfected into E. coli MRF cells. Plaques were screened for
the production of MAb NM7.3-reactive protein. Immunoreac-
tive plaques were purified, followed by in vivo plasmid excision.
Reactive clone pB1-7 was analyzed by Western blotting and
was confirmed to produce a 32-kDa antigen that reacted with
MAb NM7.3 (Fig. 2, lane 1). pB1-7 was mapped by restriction
enzymes and was found to have an internal EcoRI site. Two
subclones of the 9-kb insert were constructed in pBluescript
SKII(2) and were designated pB1-7-L (4-kb EcoR1 fragment)
and pB1-7-B (5-kb EcoRI fragment) (Fig. 3A). Subclones were
subjected to SDS-PAGE and were tested by Western blot
analysis for expression of MAb NM7.3-reactive product. pB1-
7-L expressed an approximately 25-kDa immunoreactive prod-
uct, whereas pB1-7-B did not express an immunoreactive pro-
tein (Fig. 2, lanes 2 and 4, respectively).
DNA sequence analysis. To predict a function for the im-
munoreactive 32-kDa differentially expressed protein, the
DNA sequence was determined for a region of pB1-7 that
included the open reading frame (ORF) responsible for ex-
pression of this antigen (GenBank accession no. AF127534).
BLAST comparison of the ENTREZ database to this se-
quence revealed 54% identity to the E. coli rpsB-tsf gene clus-
ter which encodes 30S ribosomal subunit protein S2 and EF-
Ts. Sequence analyses of subclones also revealed that pB1-7-L
expressed an immunoreactive protein fused the b-galactosi-
dase peptide and carried the majority of the tsf ORF while
pB1-7-B contained the entire rpsB and the 59 region of tsf (Fig.
3A and B).
Cloning of the gene expressing the 45-kDa antigen. The
lZapII expression library was screened with MAb NM183, but
no immunoreactive clones were identified (.10,000 plaques
surveyed). An alternative strategy was devised to clone the
gene encoding this antigen. MAb NM183 was found to cross-
react strongly with a ;45-kDa protein from C. trachomatis
(Fig. 4, lane 1). This molecular mass corresponds with the
chlamydial EF-Tu protein previously identified (6). To test
whether MAb NM183 reacted with this antigen, purified re-
FIG. 1. Differential expression by LCV and SCV. LCVs and SCVs were
separated by cesium chloride gradient centrifugation, and equal amounts (total
protein) were separated by SDS-PAGE and were Western blotted. (A) Cb-Mip
detected with MAb NM175. (B) A 32-kDa protein detected with MAb NM183.
(C) A 45-kDa protein detected with MAb NM7.3.
FIG. 2. Immunoreactivity of pB1-7 clones. Western blot detection of MAb
NM7.3-reactive antigens. Lane 1, pB1-7-expressed 32-kDa immunoreactive
product; lane 2, pB1-7-L-expressed major immunoreactive 25-kDa antigen and
several additional reactive bands; lane 3, MAb NM7.3-detected 32-kDa product
in C. burnetii; lane 4, pB1-7-B did not produce an immunoreactive product; lane
M, molecular mass markers.
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combinant His-tagged-chlamydial EF-Tu was obtained from
You-Xun Zhang (Boston University School of Medicine, Bos-
ton, Mass.) and was found to react strongly with MAb NM183
during Western blotting (Fig. 4, lane 2).
Therefore, the 45-kDa differentially expressed protein was
likely to be an EF-Tu of C. burnetii. EF-Tus from other bac-
teria have been previously noted to have highly conserved
regions (6). Low-degeneracy primers were developed to isolate
these conserved regions from a C. burnetii tuf gene. The first
set of PCR primers, P1 and P2, amplified a 900-bp internal
tuf-like region (confirmed by sequence analysis) from C. bur-
netii template DNA (Fig. 5). To test the immunoreactivity of
the predicted partial EF-Tu protein encoded by this PCR
product (;85% of the predicted complete gene, based upon
other bacterial EF-Tu sequences), the 900-bp PCR product
was cloned into pGEM-T cloning vector. All the resultant
clones (such as pROS100) had the 900-bp insert in a nonex-
pressing orientation with regards to the b-galactosidase pro-
moter, suggesting a negative selection pressure for clones ex-
pressing this ORF. To overcome the orientation problem,
clones were constructed in an alternate prokaryotic expression
vector pGEX4T-1 GST fusion vector which also encodes the
lacIq suppressor, conferring stringent regulation of expression.
This strategy yielded clones with inserts in the expressing ori-
entation. To determine if a GST fusion product was expressed
by these clones, proteins from IPTG-induced and uninduced
clones were probed by Western blotting with an anti-GST
antibody. Induced clones did produce a GST fusion product of
the predicted size (;65 kDa) (Fig. 6, lanes 4 and 6). However,
this protein failed to react with MAb NM183 (data not shown).
A larger clone that included the 59 region of tuf was cloned.
This strategy was based on evidence from Southern blot anal-
ysis of chromosomal digests probed with the 900-bp PCR-
amplified tuf region that C. burnetii contain both tufA and tufB
homologues. This probe hybridized with 6- and 10-kb EcoRI
fragments of chromosomal DNA (Fig. 7, lane 2). Sequence
information had revealed an internal PvuI restriction site. Four
fragments of hybridization were seen with DNA digested with
PvuI and EcoRI, suggesting two copies of the gene encoding
EF-Tu. Organization of tuf loci and its flanking genes in other
bacteria revealed conservation of tRNAs flanking the tufB
genes in other organisms. This information was used to design
an upstream primer, designated P3, based on the conserved
threonine tRNA sequence. Primers P3 and P2 amplified an
;1,200-bp product. Sequence analysis (GenBank accession no.
AF136604) confirmed this product encoded the entire N-ter-
FIG. 3. Genetic map of the C. burnetii rpsB-tsf operon. (A) The major regions of the MAb NM7.3-reactive clone and subclones used for sequence analysis and ORF
determination. (B) The genetic organization for the rpsB-tsf operon of C. burnetii, including the joint region between the two ORFs. A potential ribosomal binding site
(RBS) is underlined and immediately follows the stop codon of rpsB.
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minal region of EF-Tu as well as a weak promoter region (Fig.
5), similar to the previously characterized tufB promoter in E.
coli (15). This product was cloned into pCR2.1 TOPO-TA
(pROS103) and was shown to express a ;45-kDa antigen that
reacted with MAb NM183 during Western blotting (Fig. 8,
lane 4), confirming that EF-Tu is the immunoreactive 45-kDa
LCV-specific protein.
DISCUSSION
This study presents the identification, cloning, and sequence
analysis of two differentially expressed C. burnetii genes, des-
ignated tsf and tufB, which encode the elongation factors
EF-Ts and EF-Tu, respectively. MAbs against C. burnetii were
tested for reactivity against LCV and SCV lysates to identify
differentially expressed proteins. A 32-kDa antigen that was
upregulated more than fourfold by LCV compared to SCV and
a 45-kDa antigen that was expressed by LCV and not detected
in SCV were identified in this screen.
Cloning of the 32-kDa antigen was accomplished by the
identification of an immunoreactive plaque from a C. burnetii
genomic library with MAb NM7.3. Western blot analysis of the
immunoreactive clone, designated pB1-7, confirmed the ex-
pression of a 32-kDa protein. Restriction enzyme mapping of
pB1-7 indicated an internal EcoRI restriction site, and 4- and
5-kb fragments were subcloned (pB1-7-L and pB1-7-B1, re-
spectively). pB1-7-L encoded a 25-kDa NM7.3-reactive pro-
tein, which resulted from the expression of a fusion protein
consisting of b-galactosidase peptide and the 20-kDa 39 end of
EF-Ts, as revealed by sequence analysis. MAb NM7.3 also
recognized a ;70- to 80-kDa immunoreactive product in C.
burnetii and recombinant E. coli which is likely a oligomeric
association of EF-Ts with the translational factor, EF-Tu.
EF-Ts mediates reactivation of EF-Tu by displacing GDP and
facilitating association of GTP. Tsf is found on an operon with
rpsB (encoding small ribosomal protein S2) in C. burnetii as
with other bacteria like E. coli and Salmonella typhimurium.
The C. burnetii EF-Ts shows 53% identity and 67% similarity
to the E. coli EF-Ts at the amino acid level. The promoter lying
upstream of rpsB had typical RpoD-type -10 and -35 consensus
sequences, and the spacing between these sigma factor recog-
nition sites was characteristic of that reported in other C.
burnetii genes (16).
Cloning of the gene encoding the NM183-reactive 45-kDa
LCV-specific antigen was less direct because screening of sev-
eral C. burnetii genomic libraries yielded no immunoreactive
clones. However, MAb NM183 was found to cross-react
strongly with a 45-kDa protein from C. trachomatis, although
MAbs had been selected for their lack of cross-reactivity with
E. coli proteins. This led to the speculation that EF-Tu was the
45-kDa immunoreactive protein because of its immunodomi-
nant nature, and this view was supported by MAb NM183
cross-reactivity with purified recombinant His-tagged EF-Tu
from C. trachomatis. A tuf homologue gene encoding EF-Tu
from C. burnetii was cloned by PCR amplification using degen-
erate primers, sequences which were obtained from the highly
conserved regions of eubacterial EF-Tu sequences. A 900-bp
internal region of the tuf homologue in C. burnetii was cloned
and subcloned into the GST fusion vector pGEX4T-1. To
ensure expression of the 900-bp ORF, the 900-bp fusion pro-
tein was tested by Western blotting for reactivity against anti-
GST antibody and was found to express a fusion protein of the
predicted size. However, the fusion protein did not react with
NM183.
Our data also indicated that C. burnetii has two copies of the
tuf gene, the occurrence of which has precedence in other
bacteria like E. coli and S. typhimurium, as well as other enteric
and selected gram-positive bacteria. To clone the entire region
of the tuf homologues, the organization of various tufA- and
tufB-containing operons were compared and found to show a
conservation in the arrangement of tRNAs in the tRNA-tufB
operon. Based upon the conservation of organization of the
Thr-tRNA-tufB-Trp-tRNA sequence, primers were designed
from conserved tRNA sequences for threonine and trypto-
phan. The Thr-tRNA-based primer combined with the P2
primer yielded a 1,200-bp amplified product which contained a
region that encoded all but the 39 end of the EF-Tu-B protein.
The PCR product was cloned into pCR2.1 TOPO-TA cloning
vector and was IPTG induced to express the EF-Tu-B product.
This protein reacted with MAb NM183 during Western blot-
ting, confirming that the immunoreactive LCV-specific 45-kDa
antigen was EF-Tu.
Therefore, EF-Ts and EF-Tu, important components of the
translational machinery of the cell, were found to be differen-
tially regulated by the LCV and the SCV. EF-Tu is particularly
interesting since it is believed to be a multifunctional protein
which not only promotes binding of aminoacyl tRNA to the
ribosome, but also plays a role in transcriptional activation and
has been speculated to regulate synthesis of proteins which
respond to stress at the level of transcription. The cellular
content of EF-Tu, in E. coli for example, varies in direct pro-
portion to the growth rate, and this results from a higher rate
of tuf gene transcription in rapidly growing cells as well as a
higher translational efficiency (judged by number of transcripts
per mRNA) of tuf mRNA (27). EF-Tu has been shown to be
methylated on amino acid residue lysine 56 in a nutrient-
dependent manner, and the proposed role of this methylation
is in triggering membrane dissociation in order to carry out an
unknown intracellular regulatory function (26). In another
study, methylation of EF-Tu has been reported to slow the rate
of GTP hydrolysis in vitro (24). EF-Tu also has chaperone-like
properties and has been shown to interact with unfolded and
denatured proteins and to promote functional renaturation
FIG. 4. Immunoreactivity with NM183. Lane 1, Western blot-detected 45-
kDa antigen in C. trachomati bv. E; lane 2, NM183 reacted with purified C.
trachomatis His-tagged recombinant EF-Tu; lane 3, no reactivity with E. coli.
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(5). The observation that EF-Tu remains undetected by West-
ern blot analysis in the potentially less metabolically active, but
not inert, SCV may be accounted for by several distinct mech-
anisms. For example, EF-Tu may be less stable in SCV, allow-
ing a down regulation of vegetative protein synthesis while
allowing the synthesis of stress- or starvation-induced proteins.
The purification and separation of cell forms require several
hours of preparation once bacteria are released from host
tissues, and this may exaggerate the difference in EF-Tu. How-
ever, preliminary confocal microscopic evaluation of EF-Tu
expression by C. burnetii in infected cells supports a radically
reduced expression by many small cell forms (data not shown).
The observation that translational factors are either geneti-
cally down regulated or unstable in SCV has obvious implica-
tions in the development of a model of the functional roles of
SCV and LCV and is consistent with earlier observations (11,
18). This hypothesis obviously raises questions regarding how
these populations are maintained. For example, is there a
central regulator of gene expression that mediates transcrip-
tion of genes in SCV but remains relatively inactive or down
FIG. 5. DNA sequence of C. burnetii clone expressing EF-Tu peptide which is the MAb NM183-reactive antigen. Degenerate primers used in cloning this DNA
from the C. burnetii chromosome are represented by bold arrows over the corresponding sequences. The predicted translation of this ORF is indicated. The potential
ribosomal binding region (RBS) is underlined. The predicted threonine tRNA is noted in bold starting at bp 1. The GenBank accession no. of this sequence is
AF136604.
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regulated in LCV or vice versa (in other words, is there a RpoS
homologue that is differentially expressed in C. burnetii)? Pre-
liminary evidence suggests that C. burnetii may possess an rpos
homologue, and work is underway to clone this gene and eval-
uate SCV versus LCV expression. However, the contradiction
regarding the maintenance of two seemingly disparate popu-
lations of cells (in what seems like an equal proportion) within
the same intraphagolysosomal compartment cannot be ig-
nored. What is the trigger that induces the formation of one or
the other cell type? What is the significance? Is the event
programmed, or do random events lead to the coexistence of a
similar number of LCVs and SCVs within the same microen-
vironment? Does each individual cell type secrete some un-
known substance that alters its microenvironment and facili-
tates its own maintenance? These questions should be
addressed in future investigations.
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